GeneOne Life Science, Inc.
KRX:011000.KS
2055 (KRW) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 35,720.099 | 40,202.911 | 48,718.3 | 38,700.355 | 41,502.729 | 41,241.251 | 34,292.568 | 27,171.386 | 31,371.459 | 28,364.785 | 24,625.226 | 20,657.216 | 19,410.461 | 27,737.197 | 23,281.689 | 15,003.954 | 13,974.021 | 10,090.159 |
| Cost of Revenue
| 46,588.556 | 55,187.218 | 39,382.49 | 29,942.915 | 30,090.751 | 28,351.901 | 23,595.467 | 21,515.735 | 23,274.352 | 20,721.435 | 20,624.849 | 16,482.933 | 17,443.154 | 23,294.302 | 17,417.345 | 14,255.128 | 12,706.178 | 8,724.587 |
| Gross Profit
| -10,868.458 | -14,984.307 | 9,335.811 | 8,757.441 | 11,411.978 | 12,889.351 | 10,697.1 | 5,655.651 | 8,097.107 | 7,643.35 | 4,000.377 | 4,174.282 | 1,967.307 | 4,442.895 | 5,864.344 | 748.826 | 1,267.843 | 1,365.572 |
| Gross Profit Ratio
| -0.304 | -0.373 | 0.192 | 0.226 | 0.275 | 0.313 | 0.312 | 0.208 | 0.258 | 0.269 | 0.162 | 0.202 | 0.101 | 0.16 | 0.252 | 0.05 | 0.091 | 0.135 |
| Reseach & Development Expenses
| 3,556.099 | 7,043.382 | 12,147.371 | 11,440.903 | 8,396.387 | 5,873.937 | 5,661.165 | 8,398.116 | 3,930.969 | 830.85 | 759.493 | 2,392.179 | 2,069.609 | 697.582 | 19.43 | 5.674 | 1.042 | 14.44 |
| General & Administrative Expenses
| 1,919.163 | 2,085.434 | 1,399.5 | 777.756 | 600.162 | 834.974 | 736.395 | 782.226 | 838.862 | 713.641 | 679.39 | 658.252 | 801.809 | 816.595 | 765.703 | 724.539 | 598.26 | 578.777 |
| Selling & Marketing Expenses
| 4,097.388 | 5,456.971 | 6,046.55 | 3,017.301 | 2,533.675 | 1,060.458 | 953.949 | 800.695 | 756.875 | 793.84 | 821.82 | 819.812 | 828.55 | 764.66 | 714.028 | 1,000.091 | 678.646 | 1,000.392 |
| SG&A
| 6,016.551 | 26,340.342 | 7,446.05 | 3,795.056 | 3,133.838 | 1,895.432 | 1,690.344 | 1,582.921 | 1,595.737 | 1,507.481 | 1,501.21 | 1,478.064 | 1,630.359 | 1,581.255 | 1,479.731 | 1,724.63 | 1,276.906 | 1,579.169 |
| Other Expenses
| 22,598.006 | 0 | 29,822.312 | 21,027.77 | 18,340.855 | 13,328.978 | 3,850.036 | 3,736.22 | 76.756 | 3,260.658 | -69.256 | -1,302.177 | -223.63 | 6,722.515 | -178.123 | -21.061 | 24.552 | 207.185 |
| Operating Expenses
| 32,170.656 | 40,608.787 | 49,415.733 | 36,263.729 | 29,871.079 | 21,098.347 | 21,956.15 | 30,517.307 | 22,091.5 | 11,270.306 | 10,427.57 | 10,484.068 | 10,364.007 | 9,001.351 | 7,624.396 | 8,197.301 | 6,512.48 | 6,305.357 |
| Operating Income
| -43,039.113 | -48,368.031 | -40,079.922 | -27,506.289 | -18,459.101 | -8,208.996 | -11,259.05 | -24,861.656 | -13,994.393 | -3,626.956 | -6,427.193 | -6,309.786 | -8,396.699 | -4,745.8 | -1,760.052 | -7,448.476 | -5,244.635 | -4,939.785 |
| Operating Income Ratio
| -1.205 | -1.203 | -0.823 | -0.711 | -0.445 | -0.199 | -0.328 | -0.915 | -0.446 | -0.128 | -0.261 | -0.305 | -0.433 | -0.171 | -0.076 | -0.496 | -0.375 | -0.49 |
| Total Other Income Expenses Net
| -5,713.682 | -29,286.564 | 2,029.611 | 11,899.913 | -1,574.371 | 1,064.461 | -476.103 | 1,579.102 | -1,383.708 | 3,918.226 | 65.392 | -2,016.886 | -548.552 | 8.069 | -5,832.416 | -967.472 | -604.693 | 2,037.059 |
| Income Before Tax
| -48,752.795 | -77,654.595 | -38,054.278 | -15,616.33 | -18,226.42 | -7,144.535 | -11,735.152 | -23,282.553 | -14,399.244 | 291.27 | -6,361.801 | -8,326.671 | -8,945.251 | -4,737.73 | -7,592.468 | -8,415.948 | -5,849.328 | -2,902.726 |
| Income Before Tax Ratio
| -1.365 | -1.932 | -0.781 | -0.404 | -0.439 | -0.173 | -0.342 | -0.857 | -0.459 | 0.01 | -0.258 | -0.403 | -0.461 | -0.171 | -0.326 | -0.561 | -0.419 | -0.288 |
| Income Tax Expense
| -216.188 | 113.447 | 95.792 | 335.169 | 421.992 | 474.028 | 162.49 | 447.101 | 1,199.685 | -1,122.493 | 129.929 | 36.199 | -56.773 | 199.347 | -1,269.168 | 383.591 | 146.749 | 1,241.112 |
| Net Income
| -48,536.607 | -77,768.042 | -38,150.07 | -15,951.5 | -18,648.412 | -7,618.563 | -11,897.643 | -23,729.655 | -15,598.93 | 1,413.763 | -6,491.73 | -8,362.87 | -8,888.478 | -4,937.077 | -7,592.468 | -8,415.948 | -5,849.328 | -2,902.726 |
| Net Income Ratio
| -1.359 | -1.934 | -0.783 | -0.412 | -0.449 | -0.185 | -0.347 | -0.873 | -0.497 | 0.05 | -0.264 | -0.405 | -0.458 | -0.178 | -0.326 | -0.561 | -0.419 | -0.288 |
| EPS
| -608.81 | -1,000.23 | -492.35 | -214.86 | -258.9 | -212.16 | -301.98 | -708.55 | -478.74 | 42.43 | -1,184.66 | -308.88 | -387.74 | -234.9 | -386.59 | -468.41 | -480.68 | -231.13 |
| EPS Diluted
| -608.81 | -1,000.23 | -492.35 | -214.86 | -258.9 | -212.16 | -294.41 | -690.08 | -466.24 | 42.43 | -1,184.66 | -308.88 | -387.74 | -234.9 | -386.59 | -468.41 | -480.68 | -231.13 |
| EBITDA
| -28,635.317 | -63,698.693 | -25,321.304 | -6,540.481 | -13,639.023 | -1,822.634 | -9,050.172 | -20,335.203 | -12,027.779 | -2,502.727 | -4,582.014 | -5,611.961 | -5,745.203 | -2,169.209 | -4,373.816 | -5,445.523 | -5,128.665 | -2,466.802 |
| EBITDA Ratio
| -0.802 | -1.584 | -0.52 | -0.169 | -0.329 | -0.044 | -0.264 | -0.748 | -0.383 | -0.088 | -0.186 | -0.272 | -0.296 | -0.078 | -0.188 | -0.363 | -0.367 | -0.244 |